![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/20 | |
A61K 47/40 | |||
A61K 47/34 | |||
A61K 47/26 | |||
A61K 47/12 | |||
A61K 31/4152 | |||
A61K 31/045 | |||
A61P 9/10 | |||
A61K 9/00 |
(11) | Number of the document | 3505161 |
(13) | Kind of document | T |
(96) | European patent application number | 17845291.8 |
Date of filing the European patent application | 2017-08-23 | |
(97) | Date of publication of the European application | 2019-07-03 |
(45) | Date of publication and mention of the grant of the patent | 2021-05-12 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CN2017/098620 |
Date | 2017-08-23 |
(87) | Number | WO 2018/040989 |
Date | 2018-03-08 |
(30) | Number | Date | Country code |
201610761890 | 2016-08-29 | CN |
(72) |
WANG, Yijun, CN
|
(73) |
Neurodawn Pharmaceutical Co., Ltd.,
L3244, 3rd Floor, Chuangye Building No. 1009 Tianyuan East Road Jiangning District, Nanjing, Jiangsu 211199,
CN
Simcere Pharmaceutical Co. Ltd., No. 99, Huakang Road, Jiangbei New District, Nanjing Jiangsu 210032, CN |
(54) | SUBLINGUAL PHARMACEUTICAL COMPOSITION OF EDARAVONE AND (+)-2-BORNEOL |
SUBLINGUAL PHARMACEUTICAL COMPOSITION OF EDARAVONE AND (+)-2-BORNEOL |